UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D/A

 Under the Securities Exchange Act of 1934

(Amendment No. 2)

Healthier Choices Management Corp.
(Name of Issuer)

Common Stock, $0.0001 Par Value
(Title of Class of Securities)

922099700
(CUSIP Number)

Christopher Santi

c/o Healthier Choices Management Corp.

3800 North 28th Way, #1

Hollywood, Florida 33020

(888) 766-5351

Copies to:

Martin T. Schrier, Esq.

Cozen O’Connor

Southeast Financial Center

200 South Biscayne Blvd., Suite 3000

Miami, FL 33131

(305) 704-5940

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 31, 2021
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d -1(e), 240.13d -1(f) or 240.13d -1(g), check the following box ☐.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

 

 

 

 

Item 1. Security and Issuer.

 

This Statement relates to the common stock, par value $0.0001 per share (“Common Stock”), of Healthier Choices Management Corp., a Delaware corporation (the “Issuer”). The principal executive offices of the Issuer are located at 3800 North 28th Way, #1, Hollywood, Florida 33020.

 

Item 2. Identity and Background.

 

 

Item 3. Source and Amount of Funds or Other Considerations.

 

Since the date of the first amendment to this Schedule 13D, the Reporting Person forfeited 2,200,000,000 shares of restricted Common Stock. Other than these forfeitures, the Reporting Person has not engaged in any other transactions in the Issuer’s Common Stock, including no sales or purchases of the Common Stock.

The information set forth in Item 4 is incorporated by reference herein.

 

Item 4. Purpose of Transaction.

 

As described in Item 3 above, the Reporting Person acquired the securities identified in this Statement in connection with his service as an officer and director of the Issuer and pursuant to the Issuer’s equity compensation plan.

The Reporting Person beneficially owns 23,600,000,001 shares of Common Stock of the Issuer, with such total being comprised of (1) one share of Common Stock held, (2) 6,600,000,000 shares of the Restricted Stock, and (3) options to purchase 17,000,000,000 shares of Common Stock that are exercisable as of the date hereof or within 60 days. The Reporting Person owns 6.61% of the Issuer’s Common Stock, calculated based on 339,741,632,384 shares of Common Stock outstanding as of February 11, 2022 and assuming that the shares of Common Stock underlying the stock options are deemed outstanding pursuant to SEC Rule 13d-3(d)(1)(i). Unvested shares of restricted stock are deemed beneficially owned because grantees of unvested restricted stock under the Issuer’s 2015 Equity Incentive Plan hold the sole right to vote such shares.

The securities described in this Statement are being held by the Reporting Person for investment purposes. The Reporting Person may acquire additional Common Stock of the Issuer through compensatory grants by the Issuer or through public or private purchases. The Reporting Person may exercise the stock options described in Item 3 above and subsequently dispose of the underlying Common Stock or otherwise acquire or dispose of additional securities of the Issuer, to the extent deemed advisable in light of his general investment strategies, market conditions, or other factors. Unvested shares of restricted stock are deemed beneficially owned because grantees of unvested restricted stock under the Issuer’s 2015 Equity Incentive Plan hold the sole right to vote such shares.

The option grant agreement includes a provision that prevents the Reporting Person from exercising the Options into Common Stock to the extent (but only to the extent) that such conversion would result in the Reporting Person, or any of its affiliates, beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder) more than 19.9% of the Company’s outstanding Common Stock (the “Exercise Blocker”).  The Exercise Blocker would not currently be triggered, if all the options are exercised.

In the ordinary course of his duties as Chief Operating Officer and President of the Issuer, the Reporting Person has and expects in the future to discuss and to make decisions regarding plans or proposals with respect to the matters specified in clauses (a) through (j) of this Item 4 with the Issuer.

 

Except as described in this Statement or in his capacity as Chief Operating Officer and President of the Issuer, the Reporting Person has no plans or proposals which relate to or would result in:

 

(a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer.

 

(b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries.

 

(c) A sale or transfer of a material amount of assets of the issuer or any of its subsidiaries.

 

(d) Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board.

 

(e) Any material change in the present capitalization or dividend policy of the issuer.

 

(f) Any other material change in the issuer’s business or corporate structure, including but not limited to, if the issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company Act of 1940.

 

(g) Changes in the issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person.

 

(h) Causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of registered national securities association.

 

(i) A class of equity securities of the issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or

 

(j) Any action similar to any of those enumerated above.

The information set forth in Items 5 and 6 are incorporated by reference herein.

Item 5. Interest in Securities of the Issuer.

 

 

 

 

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

The Restricted Stock was granted pursuant to a Restricted Stock Award Agreement, dated as of August 13, 2018, pursuant to the Issuer’s 2015 Equity Incentive Plan, as amended (the “2015 Plan”).  The Form of Restricted Agreement pursuant to the 2015 Plan was filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the Commission on August 20, 2018)

The Options were granted pursuant to that certain Option Award Agreement, dated February 2, 2017 (filed as Exhibit 1 to the Schedule 13D of the Reporting Person).

Except as set forth above or set forth in the exhibits, there are no other contracts, arrangements, understandings or relationships between the Reporting Person and any other person with respect to any securities of the Issuer.

The information set forth in Item 4, 5 and 7 is incorporated by reference herein.

  

Item 7. Material to be Filed as Exhibits.

 

Exhibit 1 – Option Award Agreement dated February 2, 2017 (filed with the Schedule 13D of the Reporting Person).

Exhibit 2 - Form of Restricted Stock Agreement (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the Commission on August 20, 2018).

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

 

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

Healthier Choices Manage... (PK) (USOTC:HCMC)
Historical Stock Chart
From Jan 2023 to Feb 2023

Healthier Choices Manage... (PK) (USOTC:HCMC)
Historical Stock Chart
From Feb 2022 to Feb 2023